DPIIT recognised startup Government of India
Startup India
Sanora Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.77 Cr
▲ 39% YoY
Net profit · FY 2025
₹55.53 Lakh
Net margin 8.2%
EBITDA · FY 2025
₹75.51 Lakh
EBITDA margin 11.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹12.7 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
13
Provident fund records
Directors on board
2
As per MCA filings
About Sanora Pharmaceuticals Private Limited
Data last updated:
Sanora Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC302917. Its GSTIN is 32AAZCS5984K1ZC (Kerala).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹12.7 Lakh. It is led by directors Dinesh Krishnan and Ajithkumar Nedumpilly Anandan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.77 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹55.53 Lakh (net margin 8.2%) and EBITDA of ₹75.51 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 36% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sanorapharma.
Sanora Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0031285). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanorapharma.in.
Company details
CIN U24304MH2017PTC302917
Registration Number 302917
Incorporation Date 15 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0031285
Recognitions & Rankings of Sanora Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0031285
Contact details
Sanora Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is sanorapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4B2 Gundecha Onclave Premises Co – Operative Society Ltd Kherani Road Sakinaka And, Heri East, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanora Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sanora Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sanora Pharmaceuticals operates one associated brand: Sanorapharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sanora Pharmaceuticals offers affordable, innovative drugs for primary care worldwide. | sanorapharma.in |
Business activity
The main business activity of Sanora Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanora Pharmaceuticals Private Limited, buy the company report.
Financials of Sanora Pharmaceuticals Private Limited
FY 2025 filings availableSanora Pharmaceuticals Private Limited reported revenue of ₹6.77 Cr (up 39% YoY) for FY 2025.
Revenue · FY 2025
₹6.77 Cr ▲ 39%
Net profit · FY 2025
₹55.53 Lakh margin 8.2%
EBITDA · FY 2025
₹75.51 Lakh margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 33%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 173%
3 years · compounded
▲ 154%
5 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 39% growth in the latest year. EBITDA rose 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹55.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanora Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sanora Pharmaceuticals Private Limited
Sanora Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Krishnan | Director | 16 Jul 2025 | 1 Years 3 Months | Current |
| Ajithkumar Nedumpilly Anandan | Director | 16 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Sanora Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gliesse Pharmaceuticals Private Limited | ₹6.78 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India | |||
| Eshmun Biotech Private Limited | ₹6.77 Cr (FY 2025) | 68.0% | Bathinda, Punjab, India | |||
| Sanora Pharmaceuticals Private Limitedthis company | ₹6.77 Cr (FY 2025) | ₹55.53 Lakh | 8.2% | 39.0% | 13 | Mumbai, Maharashtra, India |
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | 7.0% | Ambernath East, Maharashtra, India | |||
| Ambitree India Private Limited | ₹6.75 Cr (FY 2024) | -4.0% | Delhi, India | |||
| Biomade Life Care Private Limited | ₹6.74 Cr (FY 2024) | 4.0% | Mohali, Punjab, India |
To see the full peer comparison of Sanora Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Sanora Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sanora Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanora Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanora Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sanora Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
13
Active EPFO establishments
1
Employee growth
-31.58%
GST
Sanora Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAZCS5984K1ZC | Kerala | Active | 31 Mar 2018 |
To see the full GST registrations and return filing status of Sanora Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sanora Pharmaceuticals Private Limited has 10 board changes on record since 2017: 4 appointments and 6 cessations. The latest: Ajithkumar Nedumpilly Anandan ceased to be Additional Director on 29 Sep 2025.
AGM
Sanora Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Ajithkumar Nedumpilly Anandan ceased to be Additional Director.
Ceased
Dinesh Krishnan ceased to be Additional Director.
Appointed
Ajithkumar Nedumpilly Anandan was appointed as Director.
Appointed
Dinesh Krishnan was appointed as Director.
Ceased
Karuppan Krishnan ceased to be Director.
Filing
Sanora Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Karthikeyan Mariappan ceased to be Additional Director.
Appointed
Karthikeyan Mariappan was appointed as Director.
Ceased
Samina Huzefa Dohadwala ceased to be Director.
Ceased
Lakshminarayanan Somarajan ceased to be Additional Director.
Appointed
Karuppan Krishnan was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Sanora Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 December 2017 (9+ years old) and is registered under CIN U24304MH2017PTC302917.
Sanora Pharmaceuticals has 2 current directors:
- Dinesh Krishnan - Director
- Ajithkumar Nedumpilly Anandan - Director
The latest financial statements of Sanora Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sanora Pharmaceuticals is 32AAZCS5984K1ZC, registered in Kerala.
The CIN (Corporate Identification Number) of Sanora Pharmaceuticals is U24304MH2017PTC302917. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanora Pharmaceuticals was incorporated on 15 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sanora Pharmaceuticals by revenue are Gliesse Pharmaceuticals Private Limited, Eshmun Biotech Private Limited, Anant Pharmaceuticals Private Limited, Ambitree India Private Limited, Biomade Life Care Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajithkumar Nedumpilly Anandan ceased to be Additional Director on 29 Sep 2025. Dinesh Krishnan ceased to be Additional Director on 29 Sep 2025. Ajithkumar Nedumpilly Anandan was appointed as Director on 16 Jul 2025. Sanora Pharmaceuticals has 10 board changes on record in total.
Yes, Sanora Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Sanora Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0031285).
Sanora Pharmaceuticals can be reached through the website sanorapharma.in. Its registered office is in Mumbai, Maharashtra, India.